Evidence map›Paper›PMID 40986416›Full record

ArticleBrain : a journal of neurology2026

The presymptomatic and early manifestations of semantic dementia.

David J Whiteside, Matthew A Rouse, P Simon Jones, Ian Coyle-Gilchrist, Alexander G Murley, Katherine Stockton, Laura E Hughes, Richard A I Bethlehem, Varun Warrier, Matthew A Lambon Ralph and 2 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Concept Cells and the Neural Bases of Human Memory.Acta physiologica (Oxford, England) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David J WhitesideDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.ORCID 0000-0002-5890-9220
Matthew A RouseMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK.ORCID 0000-0002-3157-4301
P Simon JonesDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.
Ian Coyle-GilchristDepartment of Neurology, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY, UK.
Alexander G MurleyDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.ORCID 0000-0003-0813-0670
Katherine StocktonDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.
Laura E HughesMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK.
Richard A I BethlehemDepartment of Psychology, University of Cambridge, Cambridge CB2 3EB, UK.ORCID 0000-0002-0714-0685
Varun WarrierDepartment of Psychology, University of Cambridge, Cambridge CB2 3EB, UK.
Matthew A Lambon RalphMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK.ORCID 0000-0001-5907-2488
Timothy RittmanDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.ORCID 0000-0003-1063-6937
James B RoweDepartment of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0SZ, UK.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Alzheimer's Research UK G127979Association of British NeurologistsCambridge Centre for Parkinson-Plus RG95450Medical Research Council 220258Medical Research Council G116768Medical Research Council MC_UU_00030/14Medical Research Council SUAG/092NIH HHS R01 AG032306NIH HHS U01 AG024904NIH HHS W81XWH-12-2-0012NIHR Applied Research Collaboration East of EnglandNIHR Cambridge Biomedical Research Centre MC_UU_00005/18NIHR Cambridge Biomedical Research Centre MR/R023883/1NIHR Cambridge Biomedical Research Centre NIHR203312Patrick Berthoud Charitable Trust
6 · The paper itself

Abstract

People with semantic dementia (SD) or semantic variant primary progressive aphasia typically present with marked atrophy of the anterior temporal lobe, and thereafter progress more slowly than other forms of frontotemporal dementia. This suggests a prolonged prodromal phase with accumulation of neuropathology and minimal symptoms, about which little is known. To study early and presymptomatic SD, we first examine a well-characterized cohort of people with SD recruited from the Cambridge Centre for Frontotemporal Dementia. Five people with early SD had coincidental MRI prior to the onset of symptoms or were healthy volunteers in research with anterior temporal lobe atrophy as an incidental finding. We model longitudinal imaging changes in left- and right-lateralized SD to predict atrophy at symptom onset. We then assess 61 203 participants with structural brain MRI in the UK Biobank to find individuals with imaging changes in keeping with SD but with no neurodegenerative diagnosis. To identify these individuals in the UK Biobank, we design an ensemble-based classifier, differentiating baseline structural MRI in SD from healthy controls and patients with other neurodegenerative diseases, including other causes of frontotemporal lobar degeneration. We train the classifier on a Cambridge-based cohort (SD n = 47, other neurodegenerative diseases n = 498, healthy controls n = 88) and test it on a combined cohort from the Neuroimaging in Frontotemporal Dementia study and the Alzheimer's Disease Neuroimaging Initiative (SD n = 42, other neurodegenerative disease n = 449, healthy controls n = 127). From our case series, we find people with marked atrophy 3 to 5 years before recognition of symptom onset in left- or right-predominant SD. We present right-lateralized cases with subtle multimodal semantic impairment, found concurrently with only mild behavioural disturbance. We show that imaging measures can reliably and accurately differentiate clinical SD from other neurodegenerative diseases (recall: 0.88, precision: 0.95, F1 score: 0.91). We find individuals with no neurodegenerative diagnosis in the UK Biobank with striking left-lateralized (prevalence ages 45-85, 4.8/100 000) or right-lateralized (5.9/100 000) anterior temporal lobe atrophy, with deficits on cognitive testing suggestive of semantic impairment. These individuals show progressive involvement of other cognitive domains in longitudinal follow-up. Together, our findings suggest that (i) there is a burden of incipient early anterior temporal lobe atrophy in older populations, with comparable prevalence of left- and right-sided cases from this prospective unbiased approach to identification; (ii) substantial atrophy is required for manifest symptoms, particularly in right-lateralized cases; and (iii) semantic deficits across multiple domains can be detected in the early symptomatic phase.

Indexed as

Frontotemporal DementiaAgedAtrophyBrainCohort StudiesDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedProdromal SymptomsTemporal LobeUnited Kingdommachine learning classificationsemantic behavioural variant frontotemporal dementiasemantic dementiasemantic variant primary progressive aphasia

Identifiers

PMID40986416
PMCPMC13140614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.